A widely-anticipated Alzheimer's disease drug hit pharmacy shelves on Sunday as the drug was launched in Beijing. Home-grown GV-971, the first Alzheimer's disease treatment to be approved for 17 years, is now available in DTP (direct-to-patient) pharmacies across the country. One box of 42 capsules is priced at 895 yuan (US$130). A prescription is needed to make the purchase.